SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

04 Feb 2022 Evaluate
The Sales for the quarter ended December 2021 of Rs. 1316.64 millions rose by 33.90% from Rs. 983.30 millions.Profit for the quarter ended December 2021 rises by 78.18% to Rs. 74.48  millions from Rs. 41.80 millions.Operating profit surged to 124.74 millions from the corresponding previous quarter of 89.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1316.64 983.30 33.90 3576.76 3348.13 6.83 4319.60 3069.60 40.72
Other Income 3.39 25.13 -86.51 41.68 89.78 -53.58 105.38 42.12 150.19
PBIDT 124.74 89.20 39.84 371.44 494.96 -24.96 551.22 269.81 104.30
Interest 5.77 4.17 38.37 11.38 13.43 -15.26 14.94 7.92 88.64
PBDT 118.97 85.03 39.92 360.06 481.53 -25.23 536.28 261.89 104.77
Depreciation 29.92 38.04 -21.35 89.53 112.63 -20.51 150.76 70.33 114.36
PBT 89.05 46.99 89.51 270.53 368.90 -26.67 385.52 191.56 101.25
TAX 14.57 5.19 180.73 54.17 93.52 -42.08 101.15 48.50 108.56
Deferred Tax -0.89 4.19 -121.24 -5.39 6.82 -179.03 6.50 13.07 -50.27
PAT 74.48 41.80 78.18 216.36 275.38 -21.43 284.37 143.06 98.78
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 125.28 100.00
PBIDTM(%) 9.47 9.07 4.44 10.38 14.78 -29.75 12.76 8.79 45.18

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×